Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
Yan Zhou et al · BMC · 2026
Resource access
Open the content from the main option or choose another available source.
Open access available
How to cite
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, Y. Z. E. (2026). Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant. https://doi.org/10.1186/s12985-026-03173-7
MLA
al, Yan Zhou et. "Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant." 2026. https://doi.org/10.1186/s12985-026-03173-7.
Chicago
al, Yan Zhou et. 2026. "Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant.". https://doi.org/10.1186/s12985-026-03173-7.
Harvard
al, Y. Z. E. 2026, Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant, BMC, available at: https://doi.org/10.1186/s12985-026-03173-7 [Accessed 8 Aug. 2026].
Resource details
Bibliographic information to help confirm that this is the correct material.
- Title
- Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
- Author / contributors
- Yan Zhou et al
- Publisher
- BMC
- Publication year
- 2026
- ISSN
- 1743-422X
- ISSN
- 1743-422X
- Language
- English